Chenevier-Gobeaux, C.; Ducastel, M.; Meritet, J.-F.; Ballaa, Y.; Chapuis, N.; Pene, F.; Carlier, N.; Roche, N.; Szwebel, T.-A.; Terrier, B.;
et al. Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients. J. Clin. Med. 2022, 11, 5560.
https://doi.org/10.3390/jcm11195560
AMA Style
Chenevier-Gobeaux C, Ducastel M, Meritet J-F, Ballaa Y, Chapuis N, Pene F, Carlier N, Roche N, Szwebel T-A, Terrier B,
et al. Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients. Journal of Clinical Medicine. 2022; 11(19):5560.
https://doi.org/10.3390/jcm11195560
Chicago/Turabian Style
Chenevier-Gobeaux, Camille, Morgane Ducastel, Jean-François Meritet, Yassine Ballaa, Nicolas Chapuis, Frédéric Pene, Nicolas Carlier, Nicolas Roche, Tali-Anne Szwebel, Benjamin Terrier,
and et al. 2022. "Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients" Journal of Clinical Medicine 11, no. 19: 5560.
https://doi.org/10.3390/jcm11195560
APA Style
Chenevier-Gobeaux, C., Ducastel, M., Meritet, J. -F., Ballaa, Y., Chapuis, N., Pene, F., Carlier, N., Roche, N., Szwebel, T. -A., Terrier, B., & Borderie, D.
(2022). Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients. Journal of Clinical Medicine, 11(19), 5560.
https://doi.org/10.3390/jcm11195560